These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2084942)

  • 1. A comparative study of three methods for the visualization of von Willebrand factor (vWF) multimers.
    Ledford MR; Kent JW; Civantos F
    Thromb Haemost; 1990 Dec; 64(4):569-75. PubMed ID: 2084942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex.
    Aihara M; Sawada Y; Ueno K; Morimoto S; Yoshida Y; de Serres M; Cooper HA; Wagner RH
    Thromb Haemost; 1986 Apr; 55(2):263-7. PubMed ID: 3087003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection.
    Ott HW; Griesmacher A; Schnapka-Koepf M; Golderer G; Sieberer A; Spannagl M; Scheibe B; Perkhofer S; Will K; Budde U
    Am J Clin Pathol; 2010 Feb; 133(2):322-30. PubMed ID: 20093243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor multimer analysis using a sensitive peroxidase staining method.
    Tomita Y; Harrison J; Abildgaard CF
    Thromb Haemost; 1989 Sep; 62(2):781-3. PubMed ID: 2683193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostaining of von Willebrand factor multimers on agarose gels and nitrocellulose filters.
    Perutelli P
    Haematologica; 2002 Feb; 87(2):223-4. PubMed ID: 11836176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native multimer analysis of plasma and platelet von Willebrand factor compared to denaturing separation: implication for the interpretation of satellite bands.
    Hohenstein K; Griesmacher A; Weigel G; Golderer G; Ott HW
    Electrophoresis; 2011 Jun; 32(13):1684-91. PubMed ID: 21647922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroblot and immunoperoxidase staining for rapid screening of the abnormalities of the multimeric structure of von Willebrand factor in von Willebrand's disease.
    Lombardi R; Gelfi C; Righetti PG; Lattuada A; Mannucci PM
    Thromb Haemost; 1986 Apr; 55(2):246-9. PubMed ID: 3520937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes.
    Budde U; Schneppenheim R; Plendl H; Dent J; Ruggeri ZM; Zimmerman TS
    Thromb Haemost; 1990 Apr; 63(2):312-5. PubMed ID: 2363131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved characterization of plasma von Willebrand factor heterogeneity when using 2.5% agarose gel electrophoresis.
    Mazurier C; Samor B; Goudemand M
    Thromb Haemost; 1986 Feb; 55(1):61-4. PubMed ID: 3486491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter comparison of von Willebrand factor multimer sizing techniques. Report of the Factor VIII and von Willebrand Factor Subcommittee.
    Mannucci PM; Abildgaard CF; Gralnick HR; Hill FG; Hoyer LW; Lombardi R; Nilsson IM; Tuddenham E; Meyer D
    Thromb Haemost; 1985 Dec; 54(4):873-6. PubMed ID: 3879020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of von Willebrand factor multimers by enzyme-conjugated secondary antibodies.
    Brosstad F; Kjønniksen I; Rønning B; Stormorken H
    Thromb Haemost; 1986 Apr; 55(2):276-8. PubMed ID: 3520939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
    Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of von Willebrand's disease subtypes by the analysis of multimeric composition of plasma von Willebrand factor].
    Quiroga T; Pérez M; Pereira J; Mezzano D
    Rev Med Chil; 1993 Sep; 121(9):987-93. PubMed ID: 8191164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura.
    Casonato A; Pontara E; Bertomoro A; Ossi E; Vincenti M; Girolami A; Borsatti A; Bertaglia G
    Am J Hematol; 1996 Jan; 51(1):7-11. PubMed ID: 8571941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of von Willebrand factor multimers using a commercially available enhanced chemiluminescence kit.
    Cumming AM; Wensley RT
    J Clin Pathol; 1993 May; 46(5):470-3. PubMed ID: 8320330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.